Renaissance Technologies’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $10.8M | Sell |
|
|||||
|
2025
Q2 | $15.3M | Buy |
|
|||||
|
2025
Q1 | $7.69M | Buy |
|
|||||
|
2024
Q4 | $7.26M | Buy |
|
|||||
|
2024
Q3 | $4.91M | Sell |
|
|||||
|
2024
Q2 | $3.99M | Buy |
|
|||||
|
2024
Q1 | $6.68M | Sell |
|
|||||
|
2023
Q4 | $5.93M | Buy |
|
|||||
|
2023
Q3 | $3.6M | Sell |
|
|||||
|
2023
Q2 | $3.05M | Buy |
|
|||||
|
2023
Q1 | $1.31M | Sell |
|
|||||
|
2022
Q4 | $1.67M | Sell |
|
|||||
|
2022
Q3 | $954K | Buy |
|
|||||
|
2022
Q2 | $523K | Buy |
|
|||||
|
2022
Q1 | $720K | Buy |
|
|||||
|
2021
Q4 | $1.41M | Sell |
|
|||||
|
2021
Q3 | $2.74M | Sell |
|
|||||
|
2021
Q2 | $6.93M | Buy |
|
|||||
|
2021
Q1 | $3.62M | Sell |
|
|||||
|
2020
Q4 | $4.05M | Buy |
|
|||||
|
2020
Q3 | $176K | Sell |
|
|||||
|
2020
Q2 | $1.03M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $875K | Buy |
|
|||||
|
2019
Q3 | $170K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $15.7M | Sell |
|
|||||
|
2018
Q2 | $18.7M | Sell |
|
|||||
|
2018
Q1 | $24M | Buy |
|
|||||
|
2017
Q4 | $27.1M | Buy |
|
|||||
|
2017
Q3 | $27.9M | Buy |
|
|||||
|
2017
Q2 | $14.7M | Buy |
|
|||||
|
2017
Q1 | $3.55M | Buy |
|
|||||
|
2016
Q4 | $2.17M | Buy |
|
|||||
|
2016
Q3 | $1.37M | Buy |
|
|||||
|
2016
Q2 | $182K | Sell |
|
|||||
|
2016
Q1 | $257K | Sell |
|
|||||
|
2015
Q4 | $1.41M | Sell |
|
|||||
|
2015
Q3 | $1.07M | Sell |
|
|||||
|
2015
Q2 | $3.92M | Buy |
|